Impact of insulin on microvascular blood flow and endothelial cell function in the postprandial state in patients with Type 1 diabetes

References 

1. Anderson JHJ, Brunelle RL, Keohane P, Koivisto VA, Trautmann ME, Vignati L, et al. Mealtime treatment with insulin analog improves postprandial hyperglycemia and hypoglycemia in patients with non-insulin-dependent diabetes mellitus. Archives of Internal Medicine. 1997;157:1249–1255
   • MEDLINE
2. Arora S, Smakowski P, Frykberg RG, Simeone LR, Freeman R, LoGerfo FW, et al. Differences in foot and forearm skin microcirculation in diabetic patients with and without neuropathy. Diabetes Care. 1998;21:1339–1344
   • MEDLINE
   • CrossRef
3. Brunner E, Donhof S, Langer F. Nonparametric analysis of longitudinal data in factorial experiments. New York: Wiley; 2002;
4. Corbin DOC, Young RJ, Morrison DC, Hoskins P, McDicken WN, Housley E, et al. Blood flow in the foot, polyneuropathy and foot ulceration in diabetes mellitus. Diabetologia. 1987;30:468–473
   • MEDLINE
   • CrossRef
5. Feinglos MN, Thacker CH, English J, Bethel MA, Lane JD. Modification of postprandial hyperglycemia with insulin lispro improves glucose control in patients with type 2 diabetes. Diabetes Care. 1997;20:1539–1542
   • MEDLINE
6. Flynn MD, Boolell M, Tooke JE, Watkins PJ. The effect of insulin infusion on capillary blood flow in the diabetic neuropathic foot. Diabetic Medicine. 1992;9:630–634
7. Forst T, Kunt T, Pohlmann T, Goitom K, Engelbach M, Beyer J, et al. Biological activity of C-peptide on the skin microcirculation in patients with insulin-dependent diabetes mellitus. Journal of Clinical Investigations. 1998;101:2036–2041
8. Forst T, Kunt T, Pohlmann T, Goitom K, Löbig M, Engelbach M, et al. Microvascular skin blood flow following the ingestion of 75g Glucose in healthy individuals. Experimental and Clinical Endocrinology & Diabetes. 1998;106:453–458
9. Forst T, Pfutzner A, Bauersachs R, Arin M, Bach B, Biehlmaier H, et al. Comparison of the microvascular response to transcutaneous electrical nerve stimulation and postocclusive ischemia in the diabetic foot. Journal of Diabetes and its Complications. 1997;11:291–297
   • Abstract
   • Full-Text PDF (877 KB)
   • CrossRef
10. Forst T, Pfutzner A, Kunt T, Pohlmann T, Schenk U, Bauersachs R, et al. Skin microcirculation in patients with type I diabetes with and without neuropathy after neurovascular stimulation. Clinical Science. 1998;94:255–261
11. Gale EAM. A randomized, controlled trial comparing insulin lispro with human soluble insulin in patients with type 1 diabetes on intensified insulin therapy. Diabetic Medicine. 2000;17:209–214
12. Khodabandehlou T, Zhao H, Vimeux M, Aouane F, Le Devehat C. Haemorheological consequences of hyperglycaemic spike in healthy volunteers and insulin-dependent diabetics. Clinical Hemorheology and Microcirculation. 1998;19:105–114
    • MEDLINE
13. Lalli C, Ciofetta M, Del Sindaco P, Torlone E, Pampanelli S, Compagnucci P, et al. Long-term intensive treatment of type 1 diabetes with the short-acting insulin analog lispro in variable combination with NPH insulin at mealtime. Diabetes Care. 1999;22:468–477
    • MEDLINE
    • CrossRef
14. Le Devehat C, Khodabandehlou T, Zhao H, Vimeux M. Role and limits of glycemic regulation in the pathogenesis of diabetic microangiopathy. Clinical Hemorheology and Microcirculation. 1997;17:363–370
    • MEDLINE
15. Lefebvre P, Scheen AJ. The postprandial state and risk of cardiovascular disease. Diabetic Medicine. 1998;15:S63–S68
16. McVeigh GE, Brennan GM, Johnston GD, McDermott BJ, McGrath LT, Henry WR, et al. Impaired endothelium-dependent and independent vasodilatation in patients with type 2 (non-insulin-dependent) diabetes mellitus. Diabetologia. 1992;35:771–776
    • MEDLINE
17. Parkhouse N, LeQuesne PM. Quantitative objective assessment of peripheral nociceptive C-fibre function. Journal of Neurology, Neurosurgery and Psychiatry. 1988;51:28–34
18. Poldermann KH, Stehouwer CDA, vanKamp GJ, Gooren LJG. Effects of insulin infusion on endothelium-derived vasoactive substances. Diabetologia. 1996;39:1284–1292
    • MEDLINE
    • CrossRef
19. Scherrer U, Randin D, Vollenweider P, Vollenweider L, Nicod P. Nitric oxide release accounts for insulin's vascular effects in humans. Journal of Clinical Investigation. 1994;94:2511–2515
20. Shami SK, Chittenden SJ. Microangiopathy in diabetes mellitus: II. Features, complications and investigation. Diabetes Research. 1991;17:157–168
21. Shaw JE, van Schie CH, Carrington AL, Abbott CA, Boulton AJ. An analysis of dynamic forces transmitted through the foot in diabetic neuropathy [In Process Citation]. Diabetes Care. 1998;21:1955–1959
    • MEDLINE
    • CrossRef
22. Smits P, Kapma JA, Jacobs MC, Lutterman J, Thien T. Endothelium dependent vascular relaxation in patients with type 1 diabetes. Diabetes. 1993;42:148–153
    • MEDLINE
23. Steinberg HO, Brechtel G, Johnson A, Fineberg N, Baron AD. Insulin-mediated skeletal muscle vasodilation is nitric oxide dependent. A novel action of insulin to increase nitric oxide release. Journal of Clinical Investigation. 1994;94:1172–1179
24. Steinberg HO. Insulin effects on blood flow. Current Opinion in Endocrinology & Diabetes. 1999;6:135–140
25. Tack CJ, Lutterman JA, Vervoort G, Thien T, Smits P. Activation of the sodium–potassium pump contributes to insulin-induced vasodilation in humans. Hypertension. 1996;28:426–432
    • MEDLINE
26. Tooke JE, Lins PE, Ostergren J, Adamson U, Fagrell B. The effects of intravenous insulin infusion on skin microcirculatory flow in Type 1 diabetes. International Journal of Microcirculation, Clinical and Experimental. 1985;4:69–83
27. Walmsley D, Wiles PG. Early loss of neurogenic inflammation in the human diabetic foot. Clinical Science. 1991;80:605–610